• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Mdm2、p53与细胞周期:适可而止时最好顺其自然]

[Mdm2, p53 and the cell cycle: when well enough is best left alone].

作者信息

Maréchal V

机构信息

Service de Microbiologie, Hôpital Rothschild, Paris.

出版信息

Pathol Biol (Paris). 1997 Dec;45(10):824-32.

PMID:9769946
Abstract

The mdm2 cellular protooncogene is involved in many human tumors where it has been shown to be overexpressed, including sarcomas, osteosarcomas, gliomas and others. The Mdm2 protein is believed to be oncogenic by binding and inactivating the p53 and Rb tumor suppressor gene products and by activating the E2F-1/DP-1 transcription factors, thus promoting the G1 to S phase transition. The mdm2 gene is activated transcriptionally by p53, thus forming an autoregulatory negative feedback loop. This feedback loop is important in normal cells and when cells are exposed to various genotoxic agents. By activating its own negative regulator, p53 would signal the cells to resume proliferation after a p53-mediated G1 arrest in response to DNA damage. The review aims to detail the functions of Mdm2 in normal and tumor cells. We also discuss several recent data suggesting that Mdm2 may exhibit activities unrelated to its well known function as a negative regulator of p53 activities.

摘要

mdm2细胞原癌基因参与了许多人类肿瘤,在这些肿瘤中它被证明是过度表达的,包括肉瘤、骨肉瘤、神经胶质瘤等。Mdm2蛋白被认为具有致癌性,它通过结合并使p53和Rb肿瘤抑制基因产物失活,以及激活E2F-1/DP-1转录因子,从而促进G1期向S期的转变。mdm2基因由p53转录激活,从而形成一个自动调节的负反馈环。这个反馈环在正常细胞以及细胞暴露于各种基因毒性剂时都很重要。通过激活自身的负调节因子,p53会在p53介导的G1期因DNA损伤而停滞之后,向细胞发出恢复增殖的信号。这篇综述旨在详细阐述Mdm2在正常细胞和肿瘤细胞中的功能。我们还讨论了一些最新数据,这些数据表明Mdm2可能表现出与其作为p53活性负调节因子的著名功能无关的活性。

相似文献

1
[Mdm2, p53 and the cell cycle: when well enough is best left alone].[Mdm2、p53与细胞周期:适可而止时最好顺其自然]
Pathol Biol (Paris). 1997 Dec;45(10):824-32.
2
Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.p14ARF/MDM2/p53信号通路失调是伴有G1-S期转换控制基因异常的人类星形胶质细胞瘤的一个先决条件。
Cancer Res. 2000 Jan 15;60(2):417-24.
3
The mdm2 proto-oncogene.小鼠双微体2原癌基因
Leuk Lymphoma. 1997 Jul;26(3-4):227-38. doi: 10.3109/10428199709051772.
4
MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest.在缺乏p53的情况下MDM2转化以及p107 G1期细胞周期阻滞的消除。
Oncogene. 1995 Dec 7;11(11):2445-9.
5
MDM2 oncogene as a novel target for human cancer therapy.MDM2癌基因作为人类癌症治疗的新靶点。
Curr Pharm Des. 2000 Mar;6(4):393-416. doi: 10.2174/1381612003400911.
6
Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.腺病毒介导的E2F-1基因转移可抑制MDM2表达,并有效诱导MDM2过表达的肿瘤细胞凋亡。
Clin Cancer Res. 1999 Aug;5(8):2242-50.
7
Inhibiting the p53-MDM2 interaction: an important target for cancer therapy.抑制p53-MDM2相互作用:癌症治疗的一个重要靶点。
Nat Rev Cancer. 2003 Feb;3(2):102-9. doi: 10.1038/nrc991.
8
p53-independent activities of MDM2 and their relevance to cancer therapy.MDM2的p53非依赖性功能及其与癌症治疗的相关性。
Curr Cancer Drug Targets. 2005 Feb;5(1):9-20. doi: 10.2174/1568009053332618.
9
Status of the p53, Rb and MDM2 genes in canine osteosarcoma.犬骨肉瘤中p53、Rb和MDM2基因的状态
Anticancer Res. 1998 Nov-Dec;18(6A):4449-53.
10
Induction of p53-, MDM2-, and WAF1/CIP1-like molecules in insect cells by DNA-damaging agents.
Exp Cell Res. 1995 Apr;217(2):541-5. doi: 10.1006/excr.1995.1120.